Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Philip Tong
Itch Across the Ages – Practical Guide to Assessment and Management
Dr Rupert Hinds
Abdominal Pain in Children – Practical Approach in GP
Prof Roger Chen
Practical Guide to Improving Control of T2D
A/Prof Debbie Rigby
Why Inhaler Device Design and Technique Matters
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
